PER3 rs2653342: Sleep Timing and Diurnal Preference
The rs2653342 variant is a missense coding polymorphism located within the PER3 gene, which encodes a key component of the human circadian clock machinery. Statistical studies associate this variant with variations in diurnal preference (morningness versus eveningness), delayed sleep phase tendencies, and homeostatic sleep pressure. However, overall clinical and genome-wide evidence remains limited, indicating it acts as one subtle component among many in determining sleep traits.
What each genotype means
Typical circadian timing profile
You carry two copies of the common C allele at rs2653342. In circadian clock research, this baseline genotype represents the standard reference sequence and is not typically linked to the minor variations in diurnal phase preference or sleep homeostatic shifts seen with the alternate allele. Overall scientific evidence for independent effects of this single variant remains limited, as daily sleep habits are polygenic and strongly guided by behavioral schedules and light exposure.
Found in approximately 40% to 45% of European populations and roughly 70% to 75% of East Asian populations.
Intermediate circadian phase variation
You have one copy of the C allele and one copy of the G allele. Some research into PER3 missense coding polymorphisms has reported associations between this altered sequence and modest shifts in morningness-eveningness tendency or homeostatic sleep response. However, these associations have shown mixed results across different ancestries, meaning having this variant does not reliably predict your natural sleep schedule or risk for sleep phase disorders.
Carried by approximately 45% of individuals of European ancestry and roughly 25% of individuals of East Asian ancestry.
Altered sleep timing tendency
You carry two copies of the minor G allele for this PER3 coding variant. In published candidate gene analyses, carrying homozygous alternate clock alleles has been investigated for potential influence on sleep architecture, diurnal preference, and tolerance to delayed sleep timing. The overall clinical evidence remains limited and observational, so carrying this genotype does not cause a sleep disorder or guarantee an extreme morning or evening preference.
Carried by approximately 10% to 15% of European individuals and fewer than 3% of individuals of East Asian ancestry.
Genetic Location and Molecular Biology of rs2653342
The single nucleotide polymorphism rs2653342 is situated on chromosome 1 within the coding sequence of the PERIOD3 (PER3) gene. In dbSNP records, this variant reflects an exchange between guanine and adenine alleles (commonly documented as G and A on the forward strand, corresponding to a missense substitution in the P415A/H417R functional domain). This change introduces an amino acid substitution in a region that interacts with regulatory kinases and partner clock proteins. PER3 operates alongside PER1, PER2, and Cryptochrome proteins to form the primary inhibitory feedback loop regulating 24-hour cellular timekeeping. Because the amino acid shift occurs within a central regulatory segment of the protein, investigators have hypothesized that it alters PER3 stability, phosphorylation rates, or nuclear translocation dynamics. Despite these plausible biochemical hypotheses, the precise downstream physical mechanics of rs2653342 in vivo continue to undergo investigation in molecular chronobiology models.
The Biological Role of the PER3 Gene in Sleep Architecture
The PER3 gene encodes period circadian regulator 3, an integral contributor to circadian rhythmicity and peripheral tissue synchronization. While animal knockout models show that core molecular oscillations persist without PER3, the gene appears to play a specialized, prominent role in sleep homeostasis—the biological drive to sleep that accumulates across waking hours. Tissue expression databases such as the Genotype-Tissue Expression (GTEx) project show that PER3 is dynamically transcribed across central neural structures, including the hypothalamus and cortex, as well as peripheral metabolic organs. Researchers have observed that natural sequence variations in PER3, including both coding single nucleotide variants and length repeat polymorphisms, correlate with individual differences in slow-wave sleep electroencephalographic (EEG) activity and vulnerability to cognitive deficits following sleep deprivation.
Reported Associations with Chronotype and Sleep Phase
Candidate gene investigations and targeted chronobiology cohorts have evaluated rs2653342 for its association with diurnal preference and familial delayed sleep phase traits. Individuals carrying the alternate allele have exhibited altered scores on standardized morningness-eveningness questionnaires, with some cohorts observing a statistical shift toward an evening chronotype or delayed sleep onset. Similar investigations have evaluated whether this locus modifies homeostatic sleep pressure, which governs how deeply one sleeps and how resilient one is against acute sleep loss. Nonetheless, the evidence strength for rs2653342 remains classified as limited. In large-scale, unbiased genome-wide association studies (GWAS) capturing hundreds of thousands of participants, individual sleep behaviors behave polygenically, meaning single variants like rs2653342 account for only a fractional amount of variance.
Population Distribution and Ancestry Differences
Allele frequencies for rs2653342 show substantial variability across distinct global populations cataloged in repositories such as gnomAD and dbSNP. In European reference populations, the minor allele frequency is approximately 0.35, resulting in a balanced distribution where heterozygous individuals are common and both homozygous groups are easily detected. In East Asian populations, however, the minor allele frequency is lower, at roughly 0.15, meaning homozygous alternate carriers are substantially rarer. Such differences highlight why genetic associations discovered in one ancestry cohort cannot be automatically generalized to others. Population-specific background variation and differing environmental light-dark exposures mean the measurable phenotypic effect of rs2653342 can differ considerably across global groups.
Translating Research into Real-World Sleep Health
Understanding an rs2653342 genotype provides biological insight into personal sleep tendencies, but it is not a diagnostic test for any medical sleep disorder. Possessing a genotype statistically linked to eveningness does not guarantee delayed sleep phase syndrome, nor does a morning-leaning genotype prevent sleep debt. Circadian timing is heavily directed by non-genetic factors, notably environmental sunlight exposure, artificial blue light at night, work schedules, physical activity, and sleep hygiene. If you struggle with persistent insomnia, chronic daytime fatigue, or difficulty keeping standard waking hours, genotype status alone should not guide treatment decisions. Any significant sleep disturbances or questions regarding sleep-regulating medications should be reviewed directly with a physician or sleep medicine specialist.
How common is this variant?
The minor allele frequency is approximately 0.35 in European ancestries and about 0.15 in East Asian populations, with homozygous alternate carriers being moderately common in Europe but less frequent in East Asia.
Frequently asked questions
Does my rs2653342 genotype make me a night owl?
Not necessarily. While certain alleles of rs2653342 are statistically correlated with a tendency toward eveningness in research cohorts, circadian preference is shaped by dozens of genes alongside powerful daily environmental habits.
Can testing rs2653342 diagnose delayed sleep phase syndrome?
No, rs2653342 is not a diagnostic marker for delayed sleep phase disorder or any other circadian rhythm sleep-wake disorder. Clinical sleep conditions are diagnosed through comprehensive clinical evaluations, sleep logs, and actigraphy, rather than direct-to-consumer genotyping.
Why is the evidence strength for this variant labeled as limited?
Although early candidate gene sequencing linked this missense region to sleep phase traits, massive modern genome-wide association studies show that sleep timing is determined by hundreds of variants with very small individual effects. Because rs2653342 has not consistently produced massive, standalone effects across all large cohorts, scientists treat the association with appropriate caution.
How does PER3 influence sleep homeostasis?
The PER3 protein works alongside other clock proteins to regulate daily rhythms and is expressed in brain areas controlling sleep pressure. Studies suggest variation in PER3 may modulate slow-wave brain wave activity during deep sleep and affect how people cope with acute sleep deprivation.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2653342?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PER3
This SNP is associated with chronotype scores in older adults, suggesting a role in circadian regulation.
This SNP is associated with average delta power during sleep, a marker of sleep intensity.
Common synonymous variant in PER3 tightly linked with circadian diurnal preference and morningness-eveningness tendencies.
Missense variant P415A in PER3 associated with familial advanced sleep phase syndrome and circadian phase preference.
Promoter/intronic variant of PER3 tagging circadian phase angle, diurnal preference, and homeostatic sleep pressure response to sleep loss.
Part of a well-characterized functional haplotype in PER3 influencing individual diurnal preference and susceptibility to delayed sleep phase syndrome.